Ejaz A. Shamim, MD, MS, MBA, FAAN

Dr. Shamim has a long-standing interest in the pathological process leading to both central and peripheral degenerative conditions. He has studied the neurophysiological processes that lead to aberrant movements as observed in the second leading cause of neurodegeneration, Parkinson’s disease, as well as in Alzheimer’s disease, which is the leading cause of dementia. About 80% of patients with Parkinson’s disease also have dementia. Dr. Shamim assisted with the creation of the regional memory clinics in Kaiser Permanente Mid-Atlantic States and is very involved in caring for a large number of patients with dementia, including Alzheimer’s disease and Parkinson’s disease. He is currently finishing a study on the biomarkers in Alzheimer’s disease and studying the genetics of Parkinson’s disease in the underserved population. He also has an interest in autoimmune muscle degeneration including myositis and amyotrophic lateral sclerosis and has created a scale to measure severity of focal hand dystonia.